Going Green
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hehehe... as Rodney Dangerfield said “The best part about kids is... makin’ ‘em!!!” (Back to School — great film!)
Missin’ Rodney & Robin and many others!
Thanks for your reply! I think so ... One day it will be up there with the blue-chippers of our time ! Infrastructure wasn’t there when we originally expected, but it IS coming.
$WEED $CGC
Man I’d love that! I am in the “low risk” category with this thing still but it was a surprise.... random test... “Ah if I’d have known THAT, I wouldn’t have smoked those cigars and cigarettes for those years...” ... rearview mirror is always clearer.
Seems like my lungs are OK but I wonder if this lung issue would classify as co-morbidity with Covid... Being extra cautious anyway... Not taking chances.
If in future we had this RLF-100 as a treatment for Alpha1 folks like me or those who are much WORSE, that’d be great. It affects a small population but it IS genetic so if I have children it’s kind of a dice roll on what genes they’ll have... keeping it simple: which variation of this will they have?
Same as me, I hope, and hopefully not WORSE because then that would involve regular monitoring with a very real possibility of COPD in their future...
Lots of things to factor in already when making that decision on whether or not to bring youngsters into this world!!
Wild open indeed...got’er above your $333. $340 clonk on the day perhaps? Thanks for sharing the story re: the mysterious “NowWhat1.” We like ya as “NowWhat2” without any Greek inflection ;)
So we have APHA earnings on the 14th ..... Aphria seems to be the “sector saver,” with some great brands, price points, fiscally well-managed.... Let’s run into those Earnings.
Canopy earnings ... I think we have one more “bad” one to get through, but I think it will be more “meh” than bad. And next year we will be looking good with 500+ more stores opening & hopefully fewer logistical hiccups and better price points etc... One can hope!
Great post & thank you for laying that out.... this is why I am thinking pennies to dollars into Flu Season if we continue to check these boxes going forward... Yeah important to note we’re discussing the IV part here.
I am SO interested in the inhalant and I wonder if down the line I might be able to access something like this since I have a kind of genetic “lung thing” where I don’t have quite enough liver protein to clean the lungs.... alpha1 antitrypsin deficiency...
If trials ever opened up (in future years) for folks with my “condition” I’d be interested in trying it out if it might give my lungs the extra “armour” to help prevent things like COPD etc...
Just thinkin’ out loud anyway... I know we could be a ways away from that...
Thanks for outlining these important milestones!
$RLFTF
Hey thanks Uncle Gee Gee! I appreciate it. Yeah Dr. Javitt gave us the “bad & ugly” before the “GOOD.” I am not the FDA .... in my head... 2+2=4... Ha! So EUA should be a done deal based on the fact that we’ve shown safety and “some efficacy.”
But FDA could say they need more data for a blanket drug approval. Gotcha, I think!
$RLFTF
Ah thanks for that. Learning learning... always learning ... Swiss took a few cracks at .54 (.59 resistance for us). I wanna see US crack that today!
$RLFTF
Nice ! So didn’t GILD get their EUA like 7-14days after submission? We can get ours literally any time... and that is NOT contingent on the data forthcoming — because that data is going to FDA approval & not the EUA right ?!?
Thanks for your help & contributions!!!
$RLFTF
Thanks for the lovely pics as always ! 333 makes sense there given the gaps & resistance you pointed out there (final pic).Very clear thank you.
So considering this trendline, we’re at a critical juncture here. “The boys” gonna run a bait & switch of sorts and run it back up???
Green premarket now I see $336 ? Seems like they often bring it green premarket like that and then slam it... been watching you chart zealots following this ... and the VIX ! VIX 28.90 ..... heading into more volatility ! Place yer bets.
On the drinkies.... yes ! Man, but they will be cheap cheap cheap before we know it.... just like the other 2.0 products, they’re ready to kill your wallet on the initial debut .... But now those vape cartridges (full spectrum), for example, are very competitive with the black market ($30-$40/cartridge, Canadian monopoly money dollars). Nice to see that. The
The drinks ... Houndstooth is under $4 on OCS website and I watched that come down from $5 so far.... Let’s see the price get slashed in HALF and some 2x2 or 2x3 formats come out.... $8 for 4, for example... it’s coming! “Full spectrum” cartridges have done their debut at around $60-$80!!! Insane. Now the market responds.... “we wan more cheap!” Drinks should be SO cheap because they must cost hardly anything to make lol.... Yes millions sold !! Wtf!!
So ... “that’s all I have to say about that...”
ONE other question, unrelated... Did there ever exist a “NowWhat1”? If yes, do you guys still keep in touch? Or is he chained up and charting in a basement or attic someplace? I bet he’s a wizard among men ! LOL
Enjoy your day!!! $WEED $SPY
GM $RLFTF ! Have a great day !
Yes in fact these “should” diverge from main market movement ... the poster mentioned the main indexes getting slaughtered but said RLFTF would go green a tick. I think we get more than a tick but JMHO ;)
Goodnight ! $RLFTF
From the 09/21/2020 PR — 50/50 split in those places for Neuro & RLFTF and an 80/20 split “in favour of RLF” in all other territories.
“They have agreed that NeuroRx will lead commercialization in the United States, Canada, and Israel, while Relief will lead commercialization in Europe and the rest of the world. Profits from sales will be allocated to Relief and NeuroRx on a 50/50 basis in the U.S., Canada and Israel, 85/15 (in favor of Relief) in Europe, and 80/20 (in favor of Relief) in all other territories. ”
https://www.otcmarkets.com/stock/RLFTF/news/Relief-and-NeuroRx-Announce-Partnership-for-Global-Commercialization-of-RLF-100-and-Selection-of-Commercial-Partners?id=274582
Nice Dr. Yo Tweet re: both Leronlimab & RLF word-of-mouth in the medical community:
https://twitter.com/yodoctoryo/status/1312911385664393218?s=21
As he says, with therapeutics the sheer variance in immune systems, stage of disease, etc, there is no “one size fits all.”
But it certainly appears these two therapeutics are making some noise in the medical community.
Go $RLFTF
No worries. We’re on the same team ! Let’s start fresh & have a great week :)
Excellent idea. And Thanks for your Saturday & Sunday contributions btw, much appreciated. I’ve been learning a lot about this Peptide... as a treatment, totally mind-blowing potential. It is interesting that recovered Covid patients end up having MORE of the peptide than the average individual.
Javitt’s story on Glaucoma is also wonderful ... what a guy! A total mensch...
$RLFTF
Yeah that’s right. I don’t think 102 is a reason to not be excited though, as it sounds like data submission comes this week?... as per the Jerusalem article that Mc67 kindly harvested and reposted for us.
I am not disturbed by the number of enrolled and I think this sounds to be moving through the works very quickly.
$RLFTF
NeuroRX on the cusp of releasing a life-saving COVID-19 treatment
“The Jerusalem Post” FULL TEXT
By HAGAY HACOHEN OCTOBER 4, 2020 17:12
"The DNA of our company is to go after lost causes with known molecules,” NeuroRX CEO Prof. Jonathan Javvit told the ‘Post.’
The COVID-19 virus has special protein “keys” on its surface which enable it to “unlock” Alveolar Type II cells in the lungs. These are the spikes that make the "crown," or "corona," the public is familiar with. Once in, these cells stop releasing a fatty substance (pulmonary surfactant) needed to keep healthy lungs from collapsing. This is why patients infected with the virus suffer lung failure and need to be placed on an in-tube ventilator or even an oxygenator to prevent death.
“We are so used to thinking of oxygen as a good thing that we fail to realize it is a difficult gas to work with,” NeuroRX CEO Prof. Jonathan Javvit told The Jerusalem Post. “Oxygen causes rust. In evolutionary terms, when the first life forms left the sea to begin life on land, they had to find a way to keep their lungs moist on the inside so that the gas they were breathing would not harm the delicate cells.”
Javvit and his team of scientists have been able to synthesize Aviptadil, a man-made version of human Vasoactive Intestinal Peptide (VIP). This peptide is essential for the healthy operation of Type II cells. Its discovery is a complex and fascinating story involving Middle East politics, Jewish history and how drug companies work.
Due to the pandemic, the FDA allowed Javvit to test Aviptadil in record time – and the results so far have been encouraging. The company will submit statistical data to the FDA this week.
The new drug seems able to block the reproduction of COVID-19, prevent Type II cells death and stimulate the production of white blood cells. These, in turn, secrete chemicals that help protect Type II cells from the novel coronavirus.
Doctors at three different testing sites reported to Javvit that “we’re seeing the X-ray results from patients' lungs and the results are amazing,” he said.
It should be noted that these patients were near-death during the time the drug was administered. Meaning, Aviptadil can’t prevent a person from becoming infected, but it could help save countless lives.
A Brazilian study found that patients who survive COVID-19 have twice the normal amount of VIP in their blood when compared to those who die from it. This is why NeuroRX began studies to see if it might be able to help patients who are in earlier stages of the disease.
VIP ISN’T a new thing. Javitt reflected on the irony that part of the VIP story is tied to the persecution experienced by the Coptic community in Egypt in the 1950s, which led to a young Coptic medical doctor, Dr. Sami Said, to leave his native country for the US. Said discovered VIP – which also exists in intestines, hence the name Vasoactive Intestinal Peptide – in the 1980’s, and nothing much came of it.
“Drug companies at the time weren’t interested in a peptide that is produced naturally, so you can’t patent it,” Javvit explained to the Post. “And while now it seems crucial, from the commercial viewpoint at the time, a drug that people only need for a few days isn’t lucrative to develop.”
Javvit knows a lot about public health policy because one of his professors chided him when he heard that the young medical student was going to India to help cure patients with glaucoma.
“All you’ll be doing is helping a blind beggar see,” the thoughtless man told Javvit.
Enraged, Javvit conducted a study which proved that restoring eyesight to Indian patients with the eye disease increased their family earnings by 1,500%. The patient, now able to see, was able to work – and the pressure on his family to care for him was lifted, helping the entire family advance in life.
The study triggered his life-long passion for public health policy. In the early 2000s, he helped shape the policy of the World Bank Group, which has invested billions of dollars into medical infrastructure to treat eye diseases that cause blindness.
During the interview, Javvit returned to the success of Jewish efforts in wearing down Soviet resistance to the emigration of Jewish persons from the USSR as a key example of how, with time, even unlikely ideas can become world-changing realities.
He told the Post that he learned about that power from his parents and grandparents, and recounts that one of his mother’s fondest memories is when her father took her to listen to Menachem Begin speak in New York in the early 1940s, at a time when few people believed they would see the creation of Israel.
“The DNA of our company is to go after lost causes with known molecules,” he told the Post.
In this way “we help cases the pharmaceutical companies aren’t focused on.”
https://www.jpost.com/health-science/neurorx-on-the-cusp-of-releasing-a-life-saving-covid-19-treatment-644470
You’re right... Copying and pasting deserves no credit..... So I’ll reel back those comments & will temper my enthusiasm. Maybe we should get those nonsensical SEC suspension posts back up there because clearly nobody cares???....
Thank you for being so kind & observing your “Investment Philosophy & Interests” sections etc...
“When people treat you like they don't care, believe them.”
“Favorite Quote A false witness will not go unpunished, and he who breathes out lies will not escape.”
Beauty!!! Wow! Sticky! Haha. Maybe we can get this merged with your stellar post on GEM in a brand new post and put it up there. $RLFTF
Great video. He’s looking good. I hope that he continues to improve over the next week!
No - it’s a naturally-occurring “peptide” that coats the inside of your lungs and protects them from neurosis (cell death from scarring).... So we can smoke joints and stuff and be totally fine... if that’s your thing ;)
https://en.wikipedia.org/wiki/Vasoactive_intestinal_peptide
However — they’ve synthesized VIP (RLF , rolled out by NeuroRX) so it can be used as a treatment for Covid19, which DESTROYS VIP and wreaks havoc on the lungs ....
Pretty phenomenal that this has been on the market so long as an ED med and now they are seeing positive responses in Covid patients. Truly amazing that they have managed to create a synthetic form of something naturally occurring in the body ...
As Dr. Javitt said, depending on your ethos “it was created by either ‘evolution’ or GOD.” They’ve just created a synthetic form that can be delivered via IV / inhalant and both NeuroRX & RLFTF are rolling it out, in the US & EU respectively.
Cheers & happy Saturday :)
Gk
Subbed ! Take care & enjoy your weekend !
Great day ! We really chomped through a lot at .59 there...on a Friday !! Tight trading range last couple sessions after the nonsensical bedshitting. Back up next week IMO !
Another sticky-worthy post. Amazing video. Thanks !
So milestone 2020-10-01 - YESTERDAY- https://racetoacure.stanford.edu/clinical-trials/486
Could get that update any time. Never saw the Stanford site before today either ... wow....
Thank you for providing that important distinction!
Man I must be blind - I see “Enrolment 288” ? Possibly just cell version I’m not seeing it right. Swear I read the whole thing twice lol
That’s what I am reading man. Hope you are doing OK btw. Cheers.
Yeah this is huge. 288 patients
Agreed. Fun to speculate but yes you fellas are absolutely correct .... saw that Mike Lindell was pumpin’ him on “Oleandrin” ....
https://www.huffpost.com/entry/my-pillow-guy-mike-lindell-donald-trump-oleandrin_n_5f76ff71c5b6dd94f1e91938
Oleandrin:
https://en.wikipedia.org/wiki/Oleandrin
Now of course I like RLF-100’s odds better than THAT... but you are right — don’t want to tempt fate.... Let the docs figure it out.
$RLFTF
LOVELY :) Thanks for posting this !
That’s what I tried to do originally. Lol. My last post might be a total lie.
Man, maybe you and I should both watch this:
That was a pro-Trump post. I am pro-Trump. Worded it poorly. If I hear anyone say I hope he dies, I will smack their ass around.
#24465 Is fantastic. Open to putting it out to the board too. Cheers! Enjoy your weekend, $RLFTF
That wouldn’t be appropriate. But gimme a minute and I’ll find you a good post. Thank you very much!
Absolutely. Above all.
Trading nicely in a tight range here. Break the .59/.60 again and we are rockin’ on up ! $RLFTF
Hey nice DD there :) way to go
He did make an inhalant chemical joke early on. “Told ya we had the tech!!!” I’d freakin’ love that lol. $RLFTF
Thanks for resurrecting that for us. Big if true! He’s gonna need somethin’. Place your bets ! :) $RLFTF